Uncommon Bio
2 known investors
Uncommon Bio has sold its cultivated meat platform to Vow and is now focusing on SymphoRNA, leveraging its nucleic acid delivery technology.
Biotech
Investors · 2
In the news
- Meatable Acquires Uncommon Bio's Lab-Grown Meat Platformgreenqueen.com.hk · 2025
- Uncommon Bio - Protein Directoryproteindirectory.com · 2022